|
|
|
Volumn 17, Issue 12 Suppl 14, 2003, Pages 36-40
|
|
Gemcitabine, anthracycline, and taxane combinations for advanced breast cancer.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTHRACYCLINE;
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ANTIMETABOLITE;
BRIDGED COMPOUND;
DEOXYCYTIDINE;
DRUG DERIVATIVE;
GEMCITABINE;
TAXANE;
TAXOID;
ADOLESCENT;
ADULT;
AGED;
BREAST TUMOR;
DISEASE FREE SURVIVAL;
FEMALE;
FOLLOW UP;
HOSPITALIZATION;
HUMAN;
METASTASIS;
MIDDLE AGED;
PATHOLOGY;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
REVIEW;
ADOLESCENT;
ADULT;
AGED;
ANTHRACYCLINES;
ANTIMETABOLITES, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
BRIDGED COMPOUNDS;
CLINICAL TRIALS, PHASE II;
CLINICAL TRIALS, PHASE III;
DEOXYCYTIDINE;
DISEASE-FREE SURVIVAL;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
MIDDLE AGED;
NEOPLASM METASTASIS;
SEVERITY OF ILLNESS INDEX;
TAXOIDS;
|
|
EID: 2142708274
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (11)
|
|
References (32)
|
